Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory Papillomatosis

NCT02555800 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

36

Enrollment

OTHER_GOV

Sponsor class

Conditions

Recurrent Respiratory Papillomatosis

Interventions

DRUG: Bevacizumab
DRUG: Cidofovir
OTHER: Placebo

Sponsor

Centro de Investigación en. Enfermedades Infecciosas, Mexico